TOP1/YOL006C Literature Guide Help

Other names published for TOP1: MAK1, MAK17, DNA topoisomerase 1, YOL006C

TOP1 - Substrates/Ligands/Cofactors (21)

ReferenceOther Genes Addressed
Ray Chaudhuri A, et al.  (2012) Topoisomerase I poisoning results in PARP-mediated replication fork reversal.LID - 10.1038/nsmb.2258 [doi] Nat Struct Mol Biol ()
Kim N, et al.  (2011) Mutagenic processing of ribonucleotides in DNA by yeast topoisomerase I. Science 332(6037):1561-4
Cesarini E, et al.  (2010) RNA Polymerase I Transcription Silences Noncoding RNAs at the Ribosomal DNA Locus in Saccharomyces cerevisiae. Eukaryot Cell 9(2):325-35
Di Felice F, et al.  (2008) Nucleosomes represent a physical barrier for cleavage activity of DNA topoisomerase I in vivo. Biochem J 409(3):651-6
Lotito L, et al.  (2008) Global transcription regulation by DNA topoisomerase I in exponentially growing Saccharomyces cerevisiae cells: activation of telomere-proximal genes by TOP1 deletion. J Mol Biol 377(2):311-22
Rupesh KR, et al.  (2006) Synthesis, characterization and in vitro biological activity studies of Cu-M (M=Cu(2+), Co(2+), Ni(2+), Mn(2+), Zn(2+)) bimetallic complexes. Eur J Med Chem 41(12):1494-503
Rajeshkumar NV, et al.  (2003) Induction of apoptosis in mouse and human carcinoma cell lines by Emblica officinalis polyphenols and its effect on chemical carcinogenesis. J Exp Clin Cancer Res 22(2):201-12
Redon C, et al.  (2003) Yeast histone 2A serine 129 is essential for the efficient repair of checkpoint-blind DNA damage. EMBO Rep 4(7):678-84
Trigueros S and Roca J  (2002) Failure to relax negative supercoiling of DNA is a primary cause of mitotic hyper-recombination in topoisomerase-deficient yeast cells. J Biol Chem 277(40):37207-11
Joy KL, et al.  (2000) Effect of Picrorrhiza kurroa extract on transplanted tumours and chemical carcinogenesis in mice. J Ethnopharmacol 71(1-2):261-6
Zhou BN, et al.  (2000) Isolation and biochemical characterization of a new topoisomerase I inhibitor from Ocotea leucoxylon. J Nat Prod 63(2):217-21
Reid RJ, et al.  (1999) CDC45 and DPB11 are required for processive DNA replication and resistance to DNA topoisomerase I-mediated DNA damage. Proc Natl Acad Sci U S A 96(20):11440-5
Hann CL, et al.  (1998) Intragenic suppressors of mutant DNA topoisomerase I-induced lethality diminish enzyme binding of DNA. J Biol Chem 273(47):31519-27
Nitiss JL, et al.  (1998) The bis(naphthalimide) DMP-840 causes cytotoxicity by its action against eukaryotic topoisomerase II. Biochemistry 37(9):3078-85
Reid RJ, et al.  (1997) Camptothecin sensitivity is mediated by the pleiotropic drug resistance network in yeast. J Biol Chem 272(18):12091-9
Christiansen K and Westergaard O  (1996) The effect of camptothecin on topoisomerase I catalysis. Ann N Y Acad Sci 803():50-9
Christiansen K, et al.  (1994) The covalent eukaryotic topoisomerase I-DNA intermediate catalyzes pH-dependent hydrolysis and alcoholysis. J Biol Chem 269(15):11367-73
Shen LL and Fostel JM  (1994) DNA topoisomerase inhibitors as antifungal agents. Adv Pharmacol 29B():227-44
Eng WK, et al.  (1989) Mapping of the active site tyrosine of eukaryotic DNA topoisomerase I. J Biol Chem 264(23):13373-6
Saavedra RA and Huberman JA  (1986) Both DNA topoisomerases I and II relax 2 micron plasmid DNA in living yeast cells. Cell 45(1):65-70
Goto T, et al.  (1984) The purification and characterization of DNA topoisomerases I and II of the yeast Saccharomyces cerevisiae. J Biol Chem 259(16):10422-9